Biotech Stock Performance
Search documents
Scholar Rock Shares Jump 26% After Reporting Wider Q3 Loss
RTTNews· 2025-11-14 17:05
Scholar Rock Holding Corp. (SRRK) stock rose 25.67 percent to $37.79 on Friday after the company posted a wider net loss for the third quarter. The stock opened at $34.76 and traded between $34.25 and $39.50 on the Nasdaq. Shares have moved within a 52-week range of $22.71 to $46.98. Trading volume reached 3.44 million, above the average of 2.52 million.The biotech firm reported a net loss of $102.2 million, including $18.3 million in stock-based compensation, compared to $64.5 million, including $9.7 mill ...
Sarepta Therapeutics Stock Tumbles After Trial Data
Schaeffers Investment Research· 2025-11-04 16:11
Sarepta Pharmaceuticals Inc (NASDAQ: SRPT) stock is plummeting down, down 31.4% at $16.77 at last glance. Though the biotech company reported an impressive revenue beat, a wider-than-expected loss per share and disappointing trial data for two gene-therapy treatments for Duchenne muscular dystrophy weighed.SRPT is no stranger to outsized moves, having experienced several bear gaps this year. The shares had been creeping higher since their July 24, nine-year low of $10.41 -- with help from the company's rest ...